Aprea Therapeutics
Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. We exist to ensure that cancer doesn't interrupt life's possibilities and dreams. We do this through our unique approach to synthetic lethality that is revolutionizing the future of cancer treatment.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
13
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Aprea Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- MC
Michael Carleton
Advisor Translational Medicine · Science
EmailPhone - SR
Sonia Ritzmann
Scientist · Research & Development
EmailPhone - TL
Teresa Lee
Senior Scientist · Research & Development
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Aprea Therapeutics
3 distinct titles indexed · top 3 shown.
- 2scientist
- 1advisor translational medicine
- 1senior scientist
Sign up to unlock all 4 contacts at Aprea Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Aprea Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.